Immuneering Corporation (IMRX)
NASDAQ · Healthcare
Immuneering Corporation Cash Flow 2020–2023
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Cash Flow | -45.3M | -55.0M | -49.0M | -44.1M | -30.9M | -14.6M |
| Depreciation & Amort. | 324,517 | 355,807 | 322,816 | — | — | — |
| Investing Activities | ||||||
| Capital Expenditure | 142,226 | 84,875 | 342,746 | 742,483 | 60,786 | 53,415 |
| Free Cash Flow | -45.5M | -55.1M | -49.3M | -44.8M | -30.9M | -14.7M |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — | — |
Immuneering Corporation Cash Flow — FAQ
Immuneering Corporation (IMRX) cash flow over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IMRX's cash flow history?
The chart and table above show Immuneering Corporation's cash flow by year and by quarter, including the growth rate.